Fundraising FoxMidway Pharmaceuticals
Spring House, US · Delaware corporation · 1 known investors
Find your way into Midway Pharmaceuticals
Sign up to find every way you can get introduced to Midway Pharmaceuticals
- Your email: who you already know at Midway Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Midway Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
RP
Rifat PamukcuNamed on SEC filing
Board
HA
Harry AraderBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2017
▶$300KraisedApr 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$300KraisedApr 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Harry AraderDirector
- Rifat PamukcuExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $10K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Midway Pharmaceuticals's investors?
- Midway Pharmaceuticals's investors include BioAdvance.
- How much funding has Midway Pharmaceuticals raised?
- Midway Pharmaceuticals has disclosed $300K raised across 1 round.
- Where is Midway Pharmaceuticals headquartered?
- Midway Pharmaceuticals is headquartered in Spring House, US.